What does Genesys invest in?
Genesys invests most often at Series B (100% of the rounds on record), in sectors such as Artificial Intelligence, Cloud Computing and Medical Device.
United States · Investor
Last cheque observed Apr 2019. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.
QuietCompany
1 rounds on record
Mostly Series B: 100% of its rounds
Genesys Cloud CX: AI-Powered Customer ExperienceFrom their own website
Every round we can evidence, newest first1 appearances
1 round
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
We hold 1 person at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
Acquisitions by the firm itself
Genesys invests most often at Series B (100% of the rounds on record), in sectors such as Artificial Intelligence, Cloud Computing and Medical Device.
1 investments on record, 0 of them in the last 12 months. The most recent was in Apr 2019.
Its most recent investments on record: Fusion Pharamaceuticals (Series B, Apr 2019).
The median round it joins is $105M.
No investments in the last 12 months; the latest was in Apr 2019.
Genesys is a company based in Menlo Park, United States.
Genesys was founded in 1990.
From 1 articles and filings naming it in a round, public registers and its own website, checked and rebuilt every night.
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it